Eurobio Scientific SA
PAR:ALERS

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
PAR:ALERS
Watchlist
Price: 24.355 EUR -0.39% Market Closed
Market Cap: 249.6m EUR

Wall Street
Price Targets

ALERS Price Targets Summary
Eurobio Scientific SA

Wall Street analysts forecast ALERS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALERS is 30.6 EUR with a low forecast of 30.3 EUR and a high forecast of 31.5 EUR.

Lowest
Price Target
30.3 EUR
24% Upside
Average
Price Target
30.6 EUR
26% Upside
Highest
Price Target
31.5 EUR
29% Upside
Eurobio Scientific SA Competitors:
Price Targets
TSHA
Taysha Gene Therapies Inc
280% Upside
UTHR
United Therapeutics Corp
39% Upside
NTRA
Natera Inc
30% Upside
2616
CStone Pharmaceuticals
1% Downside
ABBV
Abbvie Inc
17% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
3% Upside
086900
Medy Tox Inc
37% Upside
688428
InnoCare Pharma Ltd
9% Downside

Revenue
Forecast

Revenue Estimate
Eurobio Scientific SA

For the last 8 years the compound annual growth rate for Eurobio Scientific SA's revenue is 20%. The projected CAGR for the next 3 years is 7%.

20%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eurobio Scientific SA

The compound annual growth rate of Eurobio Scientific SA's operating income for the next 3 years is 34%.

N/A
Past Growth
34%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Eurobio Scientific SA

The compound annual growth rate of Eurobio Scientific SA's net income for the next 3 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALERS's stock price target?
Price Target
30.6 EUR

According to Wall Street analysts, the average 1-year price target for ALERS is 30.6 EUR with a low forecast of 30.3 EUR and a high forecast of 31.5 EUR.

What is Eurobio Scientific SA's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Eurobio Scientific SA's revenue is 20%. The projected CAGR for the next 3 years is 7%.

What is Eurobio Scientific SA's Operating Income forecast?
Projected CAGR
34%

The compound annual growth rate of Eurobio Scientific SA's operating income for the next 3 years is 34%.

What is Eurobio Scientific SA's Net Income forecast?
Projected CAGR
52%

The compound annual growth rate of Eurobio Scientific SA's net income for the next 3 years is 52%.

Back to Top